Use access key #2 to skip to page content.
$65.00 -1.25 (-1.89%)
10/10/2008 4:00 PM

ImClone Systems, Inc. (IMCL)

CAPS Rating:
**

A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.

View All Commentary (IMCL)

Recs

0

Avatar MattCraig (31.27) Submitted: 5/12/08 11:35 AM : Outperform Start Price: $42.72 IMCL Score: 7.64

one of two Ball Belle's come ASCO

Report this Post Replies: 0 | Reply

Featured Broker Partners